[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Clarithromycin (CAS 81103-11-9) Market Research Report 2024

March 2024 | 50 pages | ID: C97F0627B71EN
BAC Reports

US$ 2,200.00 US$ 2,650.00 -17 %
Offer valid until March 31, 2024!

Email Delivery - PDF (on default)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

Clarithromycin (CAS 81103-11-9) Market Research Report 2024 presents comprehensive data on Clarithromycin markets globally and regionally (Europe, Asia, North America etc.)

The report includes Clarithromycin description, covers its application areas and related patterns. It overviews Clarithromycin market, names Clarithromycin producers and indicates its suppliers.

Besides, the report provides Clarithromycin prices in regional markets.

In addition to the above the report determines Clarithromycin consumers in the market.

BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

We can analyze the following elements for each chemical product in any country or region:

  • capacities and production
  • consumption volume and structure
  • market price trends
  • exports and imports
  • existing technologies
  • feedstock market condition
  • market news digest
  • market forecast.

Clarithromycin (CAS 81103-11-9) Market Research Report 2024 can feature:

  • market condition and estimations, market forecast
  • chemical product ranges, trademarks, analogous products, application areas
  • regional and global producers, consumers and traders (including contact details).

1. CLARITHROMYCIN (CAS 81103-11-9)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. CLARITHROMYCIN APPLICATIONS

2.1. Clarithromycin application spheres, downstream products

3. CLARITHROMYCIN MANUFACTURING METHODS

4. CLARITHROMYCIN PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. CLARITHROMYCIN MARKET WORLDWIDE 

5.1. General Clarithromycin market situation, trends
5.2. Manufacturers of Clarithromycin
- Europe
- Asia
- North America
- Other regions
5.3. Clarithromycin suppliers (importers, local distributors)
- Europe
- Asia
- North America
- Other regions
5.4. Clarithromycin market forecast

6. CLARITHROMYCIN MARKET PRICES

6.1. Clarithromycin prices in Europe
6.2. Clarithromycin prices in Asia
6.3. Clarithromycin prices in North America
6.4. Clarithromycin prices in other regions

7. CLARITHROMYCIN END-USE SECTOR 

7.1. Clarithromycin market by application sphere
7.2. Clarithromycin downstream markets trends and prospects

*Please note that Clarithromycin (CAS 81103-11-9) Market Research Report 2024 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 5-7 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 5-7 days to update a report after an order is received.

Product Name:Clarithromycin
Synonyms:
  • (3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-6-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
  • 6-O-Methylerythromycin A
  • Antibiotic TE 31
  • Clathromycin
  • Klaricid
  • Zeclar
  • Citalopram Hydrobromide
CAS#:81103-11-9
Formula:C38H69NO13
Molecular Weight:747.95
Appearance:White solid.
Usage:A macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia.



More Publications